The results suggested that aiphanol (32) and isorhapontigenin (33) (Figure 4) could be possible alternative therapeutic option for cancers ailment, as COX-2 over expression plays significant role in cancer development and progression (Lee et al., 2001). This evidence concerns the gene PTGS2 and cancer.